Viamet Pharmaceuticals, Inc.

Release Summary

Viamet to present data for two antifungal therapies at ASM Microbe 2017. This is the first public presentation of Viamet’s successful Phase 2b results for VT-1161 in the treatment of RVVC.

Viamet Pharmaceuticals, Inc.